Current issue Athero Review

3

Štefan Tóth

8

SAA Consensus Statement EAS 2021: Triglyceride-rich lipoproteins and their remnant particles – a review of metabolism, role in atherosclerotic cardiovascular disease, and new therapeutic strategies

Branislav Vohnout, Martin Čaprnda, Ubomíra Fábryová, Anna Hlavatá, Michaela Kadurová, Ján Lietava, Daniel Pella, Katarína Rašlová, Jana Sirotiaková, Jana Tisoňová, Štefan Tóth

19

The use of fenofibrate in the prevention of diabetic retinopathy progression: an interdisciplinary consensus

Martin Prázný, Tomáš Sosna, Libor Hejsek, Jarmila Heissigerová, Michal Vrablík Za Panel Odborníků, Zuzana Zafarová

23

Determination and current management options for statin intolerance

Lukáš Olšavský, Štefan Tóth, Adriána Jarolímková

30

GLP-1 receptors agonization as an effective antiatherosclerotic strategy

Michal Vrablík

33

Cardiovascular risk in obese individuals: how to keep it under control?

Ubomíra Fábryová

38

Targeting lipoprotein(a): modification of cardiovascular risk and current treatment options

Tibor Porubän, Štefan Tóth

45

Possibilities of using telemedicine methods in the management of lipitension

Adriána Jarolímková, Patrik Buček, Štefan Tóth

53

Telemedicine in the management of lipitension – opportunities and barriers to its use in Slovakia from the patient's perspective: a questionnaire study

Štefan Tóth, Adriána Jarolímková, Patrik Buček

62

Dutch Lipid Clinic Network Score – an effective tool for the diagnosis of familial hypercholesterolemia

Katarína Rašlová, Miloslava Hučková, Soňa Wimmerová, Ján Chandoga, Miriama Juhosová

67

Research on remarkable articles from international literature

Eva Tůmová

69

28th Congress on Atherosclerosis: What did 2024 bring to dyslipidemia treatment?

Kristýna Čillíková

Athero Review - Issue 1/2025

Guidelines

Reviews

From International Literature

Annoucements

Athero Review